- $21.08m
- $1.17bn
- $2.79bn
- 53
- 84
- 10
- 47
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0.01 | ||
EV to EBITDA | 239.54 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -10.16% | ||
Return on Equity | -341.96% | ||
Operating Margin | -3.75% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 1,368.67 | 1,996.89 | 2,504.39 | 2,751.17 | 2,787.59 | 2,658.52 | 2,809.09 | 13.05% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Modivcare Inc. is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for public and private payors and their members. It provides non-emergency medical transportation (NEMT), personal care services (PCS), and in-home monitoring solutions (Monitoring). Its segments include NEMT, PCS, Monitoring, and Corporate and Other. The NEMT segment provides non-emergency medical transportation services throughout the country. The PCS segment provides nonmedical personal care and home health services. Additionally, services provided in its PCS segment include placements of non-medical personal care assistants, home health aides and nurses primarily to Medicaid patient populations in need of care monitoring and assistance performing daily living activities in the home setting. The Monitoring segment provides monitoring solutions. It provides in-home monitoring services to support patient self-management and care management operations.
Directors
- Christopher Shackelton CHM (42)
- Daniel Greenleaf PRE (56)
- L. Heath Sampson CFO (50)
- Grover Wray CHO (57)
- Jonathan Bush SVP (52)
- Kenneth Shepard CAO (40)
- Walt Meffert CIO (55)
- Todd Carter IND (58)
- David Coulter IND (73)
- Garth Graham IND (47)
- Richard Kerley IND (71)
- Leslie Norwalk IND (55)
- Stacy Saal IND (47)
- Rahul Samant IND (55)
- Frank Wright IND (73)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 20th, 1996
- Public Since
- August 19th, 2003
- No. of Shareholders
- 10
- No. of Employees
- 23,675
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
NASDAQ Global Select Market
- Shares in Issue
- 14,340,049

- Address
- 6900 LAYTON AVENUE, 12TH FLOOR, DENVER, 80237
- Web
- https://modivcare.com/
- Phone
- +1 7202582130
- Contact
- Kevin Ellich
- Auditors
- KPMG LLP
Upcoming Events for MODV
ModivCare Inc Annual Shareholders Meeting
Q2 2025 ModivCare Inc Earnings Release
Similar to MODV
Acadia Healthcare
NASDAQ Global Select Market
Addus HomeCare
NASDAQ Global Select Market
Alignment Healthcare
NASDAQ Global Select Market
Amedisys
NASDAQ Global Select Market
Aveanna Healthcare Holdings
NASDAQ Global Select Market
FAQ
As of Today at 22:06 UTC, shares in ModivCare are trading at $1.47. This share price information is delayed by 15 minutes.
Shares in ModivCare last closed at $1.47 and the price had moved by -93.86% over the past 365 days. In terms of relative price strength the ModivCare share price has underperformed the S&P500 Index by -94.33% over the past year.
The overall consensus recommendation for ModivCare is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreModivCare does not currently pay a dividend.
ModivCare does not currently pay a dividend.
ModivCare does not currently pay a dividend.
To buy shares in ModivCare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $1.47, shares in ModivCare had a market capitalisation of $21.08m.
Here are the trading details for ModivCare:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: MODV
Based on an overall assessment of its quality, value and momentum ModivCare is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in ModivCare is $5.94. That is 304.08% above the last closing price of $1.47.
Analysts covering ModivCare currently have a consensus Earnings Per Share (EPS) forecast of -$0.35 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like ModivCare. Over the past six months, its share price has underperformed the S&P500 Index by -89.25%.
As of the last closing price of $1.47, shares in ModivCare were trading -88.85% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The ModivCare PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $1.47.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
ModivCare's management team is headed by:
- Christopher Shackelton - CHM
- Daniel Greenleaf - PRE
- L. Heath Sampson - CFO
- Grover Wray - CHO
- Jonathan Bush - SVP
- Kenneth Shepard - CAO
- Walt Meffert - CIO
- Todd Carter - IND
- David Coulter - IND
- Garth Graham - IND
- Richard Kerley - IND
- Leslie Norwalk - IND
- Stacy Saal - IND
- Rahul Samant - IND
- Frank Wright - IND